Nuveen Asset Management’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-292,102
| Closed | -$347K | – | 3513 |
|
|
2022
Q1 | $347K | Buy |
292,102
+7,244
| +3% | +$8.61K | ﹤0.01% | 3094 |
|
|
2021
Q4 | $783K | Sell |
284,858
-14,034
| -5% | -$38.6K | ﹤0.01% | 2940 |
|
|
2021
Q3 | $1.71M | Sell |
298,892
-15,520
| -5% | -$88.9K | ﹤0.01% | 2742 |
|
|
2021
Q2 | $2.61M | Sell |
314,412
-49,048
| -13% | -$408K | ﹤0.01% | 2577 |
|
|
2021
Q1 | $3.17M | Sell |
363,460
-2,096
| -0.6% | -$18.3K | ﹤0.01% | 2395 |
|
|
2020
Q4 | $3.97M | Sell |
365,556
-39,745
| -10% | -$432K | ﹤0.01% | 2188 |
|
|
2020
Q3 | $4.84M | Sell |
405,301
-47,688
| -11% | -$569K | ﹤0.01% | 1930 |
|
|
2020
Q2 | $7.28M | Buy |
452,989
+75,223
| +20% | +$1.21M | ﹤0.01% | 1693 |
|
|
2020
Q1 | $5.86M | Buy |
377,766
+45,717
| +14% | +$709K | ﹤0.01% | 1614 |
|
|
2019
Q4 | $8.17M | Buy |
332,049
+21,114
| +7% | +$519K | ﹤0.01% | 1705 |
|
|
2019
Q3 | $3.21M | Sell |
310,935
-4,626
| -1% | -$47.7K | ﹤0.01% | 2181 |
|
|
2019
Q2 | $3.96M | Buy |
+315,561
| New | +$3.96M | ﹤0.01% | 2107 |
|